Human embryos commonly form abnormal nuclei during development: a mechanism of DNA damage, embryonic aneuploidy, and developmental arrest

DH Kort, G Chia, NR Treff, AJ Tanaka, T Xing… - Human …, 2016 - academic.oup.com
DH Kort, G Chia, NR Treff, AJ Tanaka, T Xing, LB Vensand, S Micucci, R Prosser, RA Lobo
Human reproduction, 2016academic.oup.com
STUDY QUESTION What is the prevalence and developmental significance of morphologic
nuclear abnormalities in human preimplantation embryos? SUMMARY ANSWER Nuclear
abnormalities are commonly found in human IVF embryos and are associated with DNA
damage, aneuploidy, and decreased developmental potential. WHAT IS KNOWN ALREADY
Early human embryonic development is complicated by genomic errors that occur after
fertilization. The appearance of extra-nuclear DNA, which has been observed in IVF, may be …
STUDY QUESTION
What is the prevalence and developmental significance of morphologic nuclear abnormalities in human preimplantation embryos?
SUMMARY ANSWER
Nuclear abnormalities are commonly found in human IVF embryos and are associated with DNA damage, aneuploidy, and decreased developmental potential.
WHAT IS KNOWN ALREADY
Early human embryonic development is complicated by genomic errors that occur after fertilization. The appearance of extra-nuclear DNA, which has been observed in IVF, may be a result of such errors. However, the mechanism by which abnormal nuclei form and the impact on DNA integrity and embryonic development is not understood.
STUDY DESIGN, SIZE, DURATION
Cryopreserved human cleavage-stage embryos (n = 150) and cryopreserved blastocysts (n = 105) from clinical IVF cycles performed between 1997 and 2008 were donated for research. Fresh embryos (n = 60) of poor quality that were slated for discard were also used. Immunohistochemical, microscopic and cytogenetic analyses at different developmental stages and morphologic grades were performed.
PARTICIPANTS/MATERIALS, SETTING, METHODS
Embryos were fixed and stained for DNA, centromeres, mitotic activity and DNA damage and imaged using confocal microscopy. Rates of abnormal nuclear formation were compared between morphologically normal cleavage-stage embryos, morphologically normal blastocysts, and poor quality embryos. To control for clinical and IVF history of oocytes donors, and quality of frozen embryos within our sample, cleavage-stage embryos (n = 52) were thawed and fixed at different stages of development and then analyzed microscopically. Cleavage-stage embryos (n = 9) were thawed and all blastomeres (n = 62) were disaggregated, imaged and analyzed for karyotype. Correlations were made between microscopic and cytogenetic findings of individual blastomeres and whole embryos.
MAIN RESULTS AND THE ROLE OF CHANCE
The frequency of microscopic nuclear abnormalities was lower in blastocysts (5%; 177/3737 cells) than in cleavage-stage embryos (16%, 103/640 blastomeres, P < 0.05) and highest in arrested embryos (65%; 44/68 blastomeres, P < 0.05). DNA damage was significantly higher in cells with microscopic nuclear abnormalities (γH2AX (phosphorylated (Ser139) histone H2A.X): 87.1%, 74/85; replication protein A: 72.9%, 62/85) relative to cells with normal nuclear morphology (γH2AX: 9.3%, 60/642; RPA: 5.6%, 36/642) (P < 0.05). Blastomeres containing nuclear abnormalities were strongly associated with aneuploidy (Fisher exact test, two-tailed, P < 0.01).
LIMITATIONS, REASONS FOR CAUTION
The embryos used were de-identified, and the clinical and IVF history was unknown.
WIDER IMPLICATIONS OF THE FINDINGS
This study explores a mechanism of abnormal embryonic development post-fertilization. While most of the current data have explored abnormal meiotic chromosome segregation in oocytes as a primary mechanism of reproductive failure, abnormal nuclear formation during early mitotic cell division in IVF embryos also plays a significant role. The detection of abnormal nuclear formation may have clinical application in noninvasive embryo selection during IVF.
STUDY FUNDING/COMPETING INTEREST(S)
The study was supported by Columbia University and the New York Stem Cell Foundation. Authors declare no competing interest.
Oxford University Press